9 Meters Biopharma Stock Price Increased Over 10% Pre-Market: Why It Happened

By Amit Chowdhry ● April 7, 2021
  • The stock price of 9 Meters Biopharma Inc (NASDAQ: NMTR) increased by over 10% pre-market. This is why it happened.

The stock price of 9 Meters Biopharma Inc (NASDAQ: NMTR) increased by over 10% pre-market. One of the biggest catalysts for the stock price increase are a few SEC reports showing several executives acquiring large positions in the company. 

These were the reports filed with the SEC:

Chief Financial Officer – Edward Sitar – Acquired 50,000 shares at $1 (report)

Chief Executive Officer – John Temperato – Acquired 100,000 shares at $1 (report)

Chairman – Mark Sirgo – Acquired 300,000 shares at $1 (report)

Earlier this week, the company had announced the closing of its previously announced underwritten public offering of 34.5 million shares of its common stock, inclusive of the full overallotment option exercised by the underwriters, at a price to the public of $1 per share.

Disclaimer: This content is intended for informational purposes. Before making any investment, you should do your own analysis.